• Info
  • Insider Ownership

Insider Trading & Ownership of Michael John Tomsicek

Location
Bedford, MA
Summary
The estimated net worth of Michael John Tomsicek is at least $118,193 dollars as of 17 Jun 2025. Michael John Tomsicek is the Chief Financial Officer of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $118.2K.
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Michael John Tomsicek files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Michael John Tomsicek

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Chief Financial Officer $118,193 06 Aug 2021
ACRV Acrivon Therapeutics, Inc. Director 13 Jun 2025
MIST Milestone Pharmaceuticals Inc. Director 10 Jun 2025

Insider Transactions Reported by Michael John Tomsicek:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.